{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:51Z","timestamp":1786119471279,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/ppo.0b013e3181db9c0a","type":"journal-article","created":{"date-parts":[[2010,4,6]],"date-time":"2010-04-06T20:47:13Z","timestamp":1270586833000},"page":"132-141","source":"Crossref","is-referenced-by-count":30,"title":["Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients With Isolated and Unresectable Liver Metastases"],"prefix":"10.1097","volume":"16","author":[{"given":"H Richard","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","first-page":"969","article-title":"Blood supply of neoplasms of the liver.","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R3-8-20210203","first-page":"3393","article-title":"Development of a technic for isolated perfusion of the liver.","volume":"61","author":"Ausman","year":"1961","journal-title":"N Y State J Med"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archsurg.1986.01400110056009","article-title":"Tumoricidal effects and patient survival after hyperthermic liver perfusion.","volume":"121","author":"Skibba","year":"1986","journal-title":"Arch Surg"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000415978","article-title":"Clinical results of hyperthermic liver perfusion for cancer in the liver.","volume":"29","author":"Skibba","year":"1988","journal-title":"Contr Oncol"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF01655820","article-title":"Rationale and indications for perfusion in liver tumors: current data.","volume":"11","author":"Schwemmle","year":"1987","journal-title":"World J Surg"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000415979","article-title":"Isolated liver perfusion with MMC\/5-FU\u2014surgical technique, pharmacokinetics, clinical results.","volume":"29","author":"Aigner","year":"1988","journal-title":"Contr Oncol"},{"key":"R8-8-20210203","first-page":"23","article-title":"The pharmacokinetics of melphalan in regional hyperthermic liver perfusion.","volume":"3","author":"Hafstr\u00f6m","year":"1990","journal-title":"Reg Cancer Treat"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","article-title":"High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.","volume":"10","author":"Lienard","year":"1992","journal-title":"J Clin Oncol"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","article-title":"Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas.","volume":"224","author":"Eggermont","year":"1996","journal-title":"Ann Surg"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.3764421","article-title":"Shock and tissue injury induced by recombinant human cachectin.","volume":"234","author":"Tracey","year":"1986","journal-title":"Science"},{"key":"R12-8-20210203","first-page":"174","article-title":"Biologic Therapy of Cancer.","author":"Alexander","year":"2000"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/CMR.0b013e3282f8e3c9","article-title":"Isolated hepatic perfusion for liver metastases of malignant melanoma.","volume":"18","author":"Rizell","year":"2008","journal-title":"Melanoma Res"},{"key":"R14-8-20210203","first-page":"127","article-title":"Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology).","author":"Alexander","year":"1999"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1200\/JCO.1998.16.4.1479","article-title":"Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.","volume":"16","author":"Alexander","year":"1998","journal-title":"J Clin Oncol"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1072-7515(00)00733-X","article-title":"Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.","volume":"191","author":"Libutti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF00801607","article-title":"Continuous intraoperative external monitoring of perfusate leak using I-131 human serum albumin during isolated perfusion of the liver and limbs.","volume":"22","author":"Barker","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"R18-8-20210203","first-page":"2316","article-title":"Cancer: Principles & Practice of Oncology.","author":"Alexander","year":"2005"},{"key":"R19-8-20210203","first-page":"784","article-title":"Role of tumor necrosis factor (TNF) on toxicity and cytokine production following isolated hepatic perfusion (IHP).","volume":"7","author":"Lans","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1245\/s10434-009-0482-9","article-title":"Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.","volume":"16","author":"Alexander","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R21-8-20210203","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/annonc\/mdn032","article-title":"Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients.","volume":"19","author":"van Iersel","year":"2008","journal-title":"Ann Oncol"},{"key":"R22-8-20210203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1245\/ASO.2005.05.003","article-title":"Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy.","volume":"12","author":"Alexander","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R23-8-20210203","first-page":"3062","article-title":"A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.","volume":"6","author":"Alexander","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R24-8-20210203","first-page":"6343","article-title":"Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.","volume":"9","author":"Alexander","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-200402000-00011","article-title":"Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver.","volume":"14","author":"Noter","year":"2004","journal-title":"Melanoma Res"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.surg.2004.06.044","article-title":"Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.","volume":"136","author":"Grover","year":"2004","journal-title":"Surgery"},{"key":"R27-8-20210203","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.ejca.2004.04.009","article-title":"Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.","volume":"40","author":"Rothbarth","year":"2004","journal-title":"Eur J Cancer"},{"key":"R28-8-20210203","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2005.00.927","article-title":"Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.","volume":"23","author":"Pingpank","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-8-20210203","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1200\/JCO.1994.12.12.2723","article-title":"Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.","volume":"12","author":"Ravikumar","year":"1994","journal-title":"J Clin Oncol"},{"key":"R30-8-20210203","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02303811","article-title":"Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.","volume":"1","author":"Curley","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"R31-8-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00686224","article-title":"Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.","volume":"33","author":"Curley","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"R32-8-20210203","first-page":"579","article-title":"Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.","volume":"114","author":"Curley","year":"1993","journal-title":"Surgery"},{"key":"R33-8-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-29512-7_1","article-title":"Isolated hepatic perfusion: treating unresectable liver metastases.","volume":"574","author":"Farma","year":"2006","journal-title":"Adv Exp Med Biol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00130404-201003000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:22Z","timestamp":1786040062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130404-201003000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e3181db9c0a","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}